Drug makers to face more business suspension

Published: 2011-03-04 06:59:00

Updated: 2011-03-04 06:59:00

Pharmaceutical companies, which are found to violate the current regulations, will be subject to more halts of business operation instead of financial penalty from the middle of this month, according to the Korea Food and Drug Administration.

So far, many companies have opted for paying the fi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK